Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapy.
Keller-Evans RB, Fleischmann Z, Sivakumar S, Sharaf R, Williams EA, Kaplan B, Sokol ES, Schrock AB, Tukachinsky H, Mata DA, Janovitz T, Lin DI, Zhong L, Lopez L, Patel NR, Frampton GM, Oxnard GR, Elvin JA, Decker B.
Keller-Evans RB, et al. Among authors: lin di.
J Mol Diagn. 2026 Jan 2:S1525-1578(25)00308-3. doi: 10.1016/j.jmoldx.2025.12.004. Online ahead of print.
J Mol Diagn. 2026.
PMID: 41485692